SCHEMBL68476

SCHEMBL68476

Cc1cccc2[nH]c[c]c12

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.41
KIF11 P52732 1/20 0.35
MAPK1 P28482 1/20 0.35
MAP2K4 P45985 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
MAPK6 Q16659 1/20 0.35
ATM Q13315 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
ACHE P22303 1/20 0.32
DAO P14920 2/20 0.32
DDO Q99489 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721649 0.74 HTR2C (0.37) CA1CA2ALDH1A1DAO
SCHEMBL321694 0.74 GPR84 (0.41) GPR84CYP1A2CYP2A6CA9TSHR
SCHEMBL1966793 0.74 FFAR1 (0.41) GPR84CA9DAODDO
SCHEMBL7456122 0.73 MEN1 (0.32)
SCHEMBL7281574 0.71
SCHEMBL27479367 0.68 HTR2C (0.34)
SCHEMBL4491526 0.68 NAPRT (0.44) CA1CA2CA7CA9ALDH1A1
SCHEMBL3482926 0.68 ATM (0.47) GPR84ATM
SCHEMBL7288943 0.67 GPR84 (0.32) GPR84
SCHEMBL10576531 0.65 KIF11 (0.39) GPR84KIF11MAPK1MAP2K4MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2464 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2023-10-26 US claimed
US-11697812-B2 Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA DICERNA PHARMACEUTICALS, INC. (US) 2023-07-11 US claimed
US-RE49118-E1 Material for organic electroluminescence device and electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2022-06-28 US claimed
US-11359198-B2 Extended dicer substrate agents and methods for the specific inhibition of gene expression DICERNA PHARMACEUTICALS, INC. (US) 2022-06-14 US claimed
CN-107556298-B Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element 出光兴产株式会社 2021-12-21 CN claimed
US-20210292757-A1 EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION NOVO NORDISK A/S (DK) 2021-09-23 US claimed
EP-3865576-A1 LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS Dicerna Pharmaceuticals, Inc. (US) 2021-08-18 EP claimed
CN-107586290-B Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element 出光兴产株式会社 2021-05-11 CN claimed
US-10870849-B2 Extended dicer substrate agents and methods for the specific inhibition of gene expression DICERNA PHARMACEUTICALS, INC. (US) 2020-12-22 US claimed
US-10837013-B2 Extended dicer substrate agents and methods for the specific inhibition of gene expression DICERNA PHARMACEUTICALS, INC. (US) 2020-11-17 US claimed
US-20120112176-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-10 US claimed
US-8101290-B2 Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) 2012-01-24 US claimed
US-20110288147-A1 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop DICERNA PHARMACEUTICALS, INC. 2011-11-24 US claimed
EP-2341943-A2 COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS Dicerna Pharmaceuticals, Inc. (US) 2011-07-13 EP claimed
US-20100331389-A1 Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides DICERNA PHARMACEUTICALS, INC. 2010-12-30 US claimed
WO-2010033225-A2 COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS DICERNA PHARMACEUTICALS, INC. (US) 2010-03-25 WO claimed
US-20090102356-A1 NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) 2009-04-23 US claimed
US-20090043116-A1 HETERO-POLYCYCLIC COMPOUNDS, AND COLORING MATTERS, PIGMENTS, DYES, COLOR-CHANGING MATERIAL COMPOSITIONS, AND COLOR-CHANGING FILMS, MADE BY USING THE COMPOUNDS IDEMITSU KOSAN CO., LTD. (JP) 2009-02-12 US claimed
EP-1828215-A2 OLIGONUCLEOTIDES COMPRISING A MODIFIED OR NON-NATURAL NUCLEOBASE Alnylam Pharmaceuticals Inc. (US) 2007-09-05 EP claimed
WO-2006093526-A2 OLIGONUCLEOTIDES COMPRISING A MODIFIED OR NON-NATURAL NUCLEOBASE ALNYLAM PHARMACEUTICALS, INC. (US) 2006-09-08 WO claimed